The Study of Drug SCT510A in Patients With Wet Age-related Macular Degeneration (wAMD)

NCT04564937 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Wet Age-related Macular Degeneration

Interventions

DRUG: SCT510A

Sponsor

Sinocelltech Ltd.